Regeneron Speeding Development Of mAb To Treat Ebola
This article was originally published in The Pink Sheet Daily
Executive Summary
Regeneron tells Senate Appropriations Committee about its research in advance of hearing on Ebola; NIAID/GSK vaccine to enter Phase II/III trials in West Africa by end of the year.